TY - JOUR
T1 - Long term development of diastolic dysfunction and heart failure with preserved left ventricular ejection fraction in heart transplant recipients
AU - Vejpongsa, Pimprapa
AU - Torre-Amione, Guillermo
AU - Marcos-Abdala, Hernan G.
AU - Kumar, Salil
AU - Youker, Keith
AU - Bhimaraj, Arvind
AU - Nagueh, Sherif F.
N1 - Funding Information:
Funded by TMH PO, SPG Performance Grant to Dr. Pimprapa Vejpongsa.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/3/9
Y1 - 2022/3/9
N2 - Heart transplant recipients (HTX) have several risk factors for heart failure which can trigger pro-inflammatory and fibrosis factors and set into motion pathophysiologic changes leading to diastolic dysfunction and HFpEF. The objective of the study was to determine if HTX recipients with dyspnea have diastolic dysfunction and HFpEF. Twenty-five HTX were included. LV systolic and diastolic functions were evaluated using conductance catheters to obtain pressure volume loops. LV function was assessed at rest and during moderate intensity exercise of the upper extremities. A significant increase occurred in LV minimal pressure (3.7 ± 3.3 to 6.5 ± 3.5 mmHg) and end diastolic pressure or EDP (11.5 ± 4 to 18 ± 3.8 mmHg, both P < 0.01) with exercise. With exercise, the time constant of LV relaxation shortened in 2, was unchanged in 3, and increased in the remaining patients (group results: rest 40 ± 11.6 vs 46 ± 9 ms, P < 0.01). LV chamber stiffness constant was abnormally increased in all but 2 patients. Indices of LV systolic properties were normal at rest but failed to augment with exercise. In 15 who agreed to blood draw, inflammation and fibrosis markers were obtained. A significant association was observed between LV EDP and Pro-Col III N-terminal (r = 0.58, P = 0.024) and IL-1-soluble receptor (r = 0.59, P = 0.02) levels. HTX have diastolic dysfunction and can develop HFpEF several years after cardiac transplantation. The abnormally increased LV chamber stiffness and the prolongation or lack of shortening of the time constant of LV relaxation with exercise are the underlying reasons behind the observed changes in LV diastolic pressures with exercise.
AB - Heart transplant recipients (HTX) have several risk factors for heart failure which can trigger pro-inflammatory and fibrosis factors and set into motion pathophysiologic changes leading to diastolic dysfunction and HFpEF. The objective of the study was to determine if HTX recipients with dyspnea have diastolic dysfunction and HFpEF. Twenty-five HTX were included. LV systolic and diastolic functions were evaluated using conductance catheters to obtain pressure volume loops. LV function was assessed at rest and during moderate intensity exercise of the upper extremities. A significant increase occurred in LV minimal pressure (3.7 ± 3.3 to 6.5 ± 3.5 mmHg) and end diastolic pressure or EDP (11.5 ± 4 to 18 ± 3.8 mmHg, both P < 0.01) with exercise. With exercise, the time constant of LV relaxation shortened in 2, was unchanged in 3, and increased in the remaining patients (group results: rest 40 ± 11.6 vs 46 ± 9 ms, P < 0.01). LV chamber stiffness constant was abnormally increased in all but 2 patients. Indices of LV systolic properties were normal at rest but failed to augment with exercise. In 15 who agreed to blood draw, inflammation and fibrosis markers were obtained. A significant association was observed between LV EDP and Pro-Col III N-terminal (r = 0.58, P = 0.024) and IL-1-soluble receptor (r = 0.59, P = 0.02) levels. HTX have diastolic dysfunction and can develop HFpEF several years after cardiac transplantation. The abnormally increased LV chamber stiffness and the prolongation or lack of shortening of the time constant of LV relaxation with exercise are the underlying reasons behind the observed changes in LV diastolic pressures with exercise.
KW - Fibrosis
KW - Heart Failure
KW - Heart Transplantation/adverse effects
KW - Humans
KW - Stroke Volume/physiology
KW - Ventricular Dysfunction, Left
KW - Ventricular Function, Left/physiology
UR - http://www.scopus.com/inward/record.url?scp=85126080709&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126080709&partnerID=8YFLogxK
U2 - 10.1038/s41598-022-07888-9
DO - 10.1038/s41598-022-07888-9
M3 - Article
C2 - 35264640
AN - SCOPUS:85126080709
VL - 12
SP - 3834
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 3834
ER -